newsfilter
← Latest News
ACCESS Newswire·

Edesa Biotech Reports Fiscal Year 2023 Results

TORONTO, ON / ACCESSWIRE / December 15, 2023 / Edesa Biotech, Inc. , a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today